Bringing the clinical trial to the patient with innovation and in-home solutions
Integrated end-to-end approach incorporating digital endpoints, trial design, execution and reporting.
Patient assessments in-home or at an alternative convenient site to reduce patient burden and increase patient engagement.
Decentralised Clinical Trials (DCTs) have the potential to improve recruitment and retention, and increase patient diversity, by putting the patient at the centre of clinical trial design.
Decentralised and hybrid trials bring a wide range of benefits to the patient and the sponsor. However, every study needs to be assessed for suitability and requires a framework based on a range of different aspects and considerations. You need a partner who can guide you through the choices and support you in developing a solution that works specifically for your study.
ICON is already deploying decentralised and hybrid clinical trials on a global basis in multiple therapeutic areas and will support you in navigating the assessment, planning and execution.
Regulatory guidance for protocol optimisation and compliance.
Digital solutions for education and automation to increase efficiency in clinical trials
Patient reported outcomes through all stages of drug and device development
Supporting patients and caregivers in studies and disease management programs
Innovative solutions for patient randomisation and logistical support of investigational product supply
Optimising real world data use to drive effective outcomes
Bringing the trial to the patient
Remote monitoring and leveraging wearable devices and sensors in clinical trials
The flexibility to keep your trials on track
Harmonising data and services for more integrated decentralised clinical trials
In addition to addressing the challenge of patient recruitment and retention, DCTs bring other benefits to your study including:
Insights from ICON covering all aspects of decentralised and hybrid trials including patient centricity, digital health technologies, in-home clinical visits and remote monitoring.Read more ICON insights